Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab (Anti IL-6 Monoclonal Antibody) in Patients with High-Risk Smoldering Multiple Myeloma

Timothy Brighton, Simon J. Harrison, MBBS MRCP (uk) MRCPath (uk) PhD, David Ghez, Brendan M. Weiss, MD, Andreas Kirsch, Hila Magen, MD, Mercedes Gironella, Dra., Albert Oriol, MD, Matthew Streetly, BMBS, MRCP, MRCPath, Xiang Qin, Rajesh Bandekar, Peter Hu, Ming Qi, MD PhD, Sepideh Nemat, MD PhD, Hartmut Goldschmidt, MD

Blood (2017) 130 (Supplement 1): 3155.

https://doi.org/10.1182/blood.V130.Suppl_1.3155.3155

Published: 2017

Journal Articles

Real-World Use of Pomalidomide and Dexamethasone in Double Refractory Multiple Myeloma: A Multicentre UK Experience

Nicola Maciocia, MBChB, BSc, MRCP, Andrew Melville, MBBS, MA (Cantab), MRCP, Paul Michael Maciocia, BSc, MBBS, MRCP, Simon Cheesman, BPharm, Faye Sharpley, MBBChir, MA, MRCP, MSc, Karthik Ramasamy, MD PhD, Matthew Streetly, BMBS, MRCP, MRCPath, Matthew W Jenner, MD, Reuben Benjamin, MB, BS, FRCPath, Stephen A Schey, MD, Rakesh Popat, Shirley D'Sa, Ali Rismani, MBBS, Kwee L Yong, Neil Rabin

Blood (2016) 128 (22): 3312.

https://doi.org/10.1182/blood.V128.22.3312.3312

Published: 2016

Journal Articles

BK Virus (BKV) Associated Haemorrhagic Cystitis Is Associated with Graft Versus Host Disease (GVHD) and Significant Morbidity Post Haematopoietic Stem Cell Transplant (HSCT).

Alesia Abigael Hunt, MBChB MRCP, Anjum Bashir Khan, MBChB, MRCP, Donal McLornan, MD, PhD, Majid A Kazmi, BmedBiol MB ChB MRCP(UK) MRCPath, Matthew Streetly, BMBS, MRCP, MRCPath, Victor Noriega, MD, Eithne MacMahon, Kavita Raj, MD, PhD, MRCP, FRCPath

Blood (2012) 120 (21): 3040.

https://doi.org/10.1182/blood.V120.21.3040.3040

Published: 2012

Journal Articles

Pomalidomide Monotherapy for Relapsed Myeloma Is Associated with Excellent Responses and Prolonged Progression Free and Overall Survival.

Matthew Streetly, BMBS, MRCP, MRCPath, Orla Stewart, RN, Kylie Gyertson, RN, Majid A. Kazmi, Steve Schey

Blood (2009) 114 (22): 3878.

https://doi.org/10.1182/blood.V114.22.3878.3878

Published: 2009

Journal Articles

GCS-100 Targets Apoptosis and Cell Cycle Regulation in Myeloma Cells.

Matthew Streetly, BMBS, MRCP, MRCPath, Lenushka Maharaj, Simon P Joel, Finbarr E Cotter, FRCP, FRCPath, PhD

Blood (2009) 114 (22): 4923.

https://doi.org/10.1182/blood.V114.22.4923.4923

Published: 2009

NARROW

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab (Anti IL-6 Monoclonal Antibody) in Patients with High-Risk Smoldering Multiple Myeloma

Real-World Use of Pomalidomide and Dexamethasone in Double Refractory Multiple Myeloma: A Multicentre UK Experience

BK Virus (BKV) Associated Haemorrhagic Cystitis Is Associated with Graft Versus Host Disease (GVHD) and Significant Morbidity Post Haematopoietic Stem Cell Transplant (HSCT).

Pomalidomide Monotherapy for Relapsed Myeloma Is Associated with Excellent Responses and Prolonged Progression Free and Overall Survival.

GCS-100 Targets Apoptosis and Cell Cycle Regulation in Myeloma Cells.

Email alerts

ASH Publications

American Society of Hematology

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab (Anti IL-6 Monoclonal Antibody) in Patients with High-Risk Smoldering Multiple Myeloma

Real-World Use of Pomalidomide and Dexamethasone in Double Refractory Multiple Myeloma: A Multicentre UK Experience

BK Virus (BKV) Associated Haemorrhagic Cystitis Is Associated with Graft Versus Host Disease (GVHD) and Significant Morbidity Post Haematopoietic Stem Cell Transplant (HSCT).

Pomalidomide Monotherapy for Relapsed Myeloma Is Associated with Excellent Responses and Prolonged Progression Free and Overall Survival.

GCS-100 Targets Apoptosis and Cell Cycle Regulation in Myeloma Cells.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only